Free Trial

Alvotech (ALVO) Financials

Alvotech logo
$8.60 +0.07 (+0.82%)
Closing price 04:00 PM Eastern
Extended Trading
$8.57 -0.03 (-0.35%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Alvotech

Annual Income Statements for Alvotech

This table shows Alvotech's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
-164 -102 -514 -552 -232
Consolidated Net Income / (Loss)
-170 -102 -514 -552 -232
Net Income / (Loss) Continuing Operations
-170 -102 -514 -552 -232
Total Pre-Tax Income
-292 -149 -552 -651 -218
Total Operating Income
-138 -299 -522 -644 -145
Total Gross Profit
69 -23 -154 -335 92
Total Revenue
69 94 98 93 580
Operating Revenue
67 91 96 91 578
Other Revenue
2.83 2.91 1.99 1.95 2.30
Total Cost of Revenue
0.00 117 253 428 488
Operating Cost of Revenue
0.00 117 253 428 488
Total Operating Expenses
207 275 367 309 237
Selling, General & Admin Expense
59 84 187 77 66
Research & Development Expense
148 191 181 211 171
Impairment Charge
- 0.00 0.00 22 0.00
Total Other Income / (Expense), net
-153 149 -30 -7.15 -72
Interest Expense
162 -152 27 0.00 69
Interest & Investment Income
5.61 - 0.00 0.00 -2.97
Other Income / (Expense), net
3.22 -2.42 -2.59 -7.15 0.00
Income Tax Expense
-122 -48 -38 -99 14
Basic Earnings per Share
($1.82) ($0.92) ($2.60) ($2.43) ($0.87)
Weighted Average Basic Shares Outstanding
- - 248.65M 266.82M 301.81M
Diluted Earnings per Share
($1.82) ($0.92) ($2.60) ($2.43) ($0.87)
Weighted Average Diluted Shares Outstanding
- - 248.65M 266.82M 301.81M
Weighted Average Basic & Diluted Shares Outstanding
- - 248.65M 266.82M 301.81M

Quarterly Income Statements for Alvotech

No quarterly income statements for Alvotech are available.


Annual Cash Flow Statements for Alvotech

This table details how cash moves in and out of Alvotech's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
-36 -14 -561 -57 -519
Net Cash From Operating Activities
-61 -228 -523 -312 -466
Net Cash From Continuing Operating Activities
-61 -247 -523 -307 -466
Net Income / (Loss) Continuing Operations
-170 -102 -514 -552 -232
Consolidated Net Income / (Loss)
-170 -102 -514 -552 -232
Depreciation Expense
16 18 20 24 31
Non-Cash Adjustments To Reconcile Net Income
207 -132 1.67 234 -120
Changes in Operating Assets and Liabilities, net
-114 -32 -31 -13 -145
Net Cash From Investing Activities
-7.41 -41 -38 -46 -54
Net Cash From Continuing Investing Activities
-7.41 -41 -38 -46 -54
Purchase of Property, Plant & Equipment
-7.49 -41 -38 -46 -54
Net Cash From Financing Activities
21 255 0.00 301 0.00
Net Cash From Continuing Financing Activities
21 262 0.00 310 0.00

Quarterly Cash Flow Statements for Alvotech

No quarterly cash flow statements for Alvotech are available.


Annual Balance Sheets for Alvotech

This table presents Alvotech's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Total Assets
598 828 950 1,221
Total Current Assets
120 231 195 455
Cash & Equivalents
18 66 11 51
Restricted Cash
10 25 26 0.00
Accounts Receivable
31 35 42 160
Inventories, net
39 71 74 128
Other Current Assets
33 58 67 115
Plant, Property, & Equipment, net
79 221 237 285
Plant, Property & Equipment, gross
79 221 237 285
Total Noncurrent Assets
382 344 492 482
Long-Term Investments
55 49 18 0.00
Goodwill
12 12 12 11
Intangible Assets
22 26 19 21
Noncurrent Deferred & Refundable Income Taxes
170 209 310 298
Other Noncurrent Operating Assets
123 49 133 152
Total Liabilities & Shareholders' Equity
598 828 950 1,221
Total Liabilities
734 1,393 1,883 1,634
Total Current Liabilities
112 167 261 193
Short-Term Debt
2.77 20 38 33
Accounts Payable
29 50 81 67
Current Deferred & Payable Income Tax Liabilities
0.84 0.93 0.93 0.20
Other Current Liabilities
79 96 141 93
Total Noncurrent Liabilities
622 1,226 1,622 1,441
Long-Term Debt
398 1,125 922 1,036
Capital Lease Obligations
115 35 106 112
Noncurrent Deferred & Payable Income Tax Liabilities
0.15 0.31 0.05 1.81
Other Noncurrent Operating Liabilities
45 57 594 291
Total Equity & Noncontrolling Interests
-136 -564 -932 -413
Total Preferred & Common Equity
-136 -564 -932 -413
Preferred Stock
1,000 1,058 1,230 2,007
Total Common Equity
-1,136 -1,623 -2,162 -2,420
Common Stock
0.14 2.13 2.28 2.83
Retained Earnings
-1,141 -1,654 -2,206 -2,438
Other Equity Adjustments
4.67 29 41 15

Quarterly Balance Sheets for Alvotech

No quarterly balance sheets for Alvotech are available.


Annual Metrics and Ratios for Alvotech

This table displays calculated financial ratios and metrics derived from Alvotech's official financial filings.

Metric 2020 2021 2022 2023 2024
Growth Metrics
- - - - -
Revenue Growth
0.00% 35.25% 4.47% -5.21% 523.81%
EBITDA Growth
0.00% -139.85% -78.20% -24.39% 81.83%
EBIT Growth
0.00% -124.08% -74.21% -24.17% 77.70%
NOPAT Growth
0.00% -117.08% -74.75% -23.41% 77.45%
Net Income Growth
0.00% 40.31% -405.97% -7.43% 57.98%
EPS Growth
0.00% 49.45% -182.61% 6.54% 64.20%
Operating Cash Flow Growth
0.00% -274.34% -129.16% 40.30% -49.14%
Free Cash Flow Firm Growth
0.00% 0.00% -7.39% 90.31% -1,306.24%
Invested Capital Growth
0.00% 0.00% 60.02% -83.70% 824.37%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - -
Gross Margin
100.00% -24.94% -157.32% -360.12% 15.82%
EBITDA Margin
-169.77% -301.06% -513.52% -673.86% -19.63%
Operating Margin
-198.04% -317.85% -531.68% -692.20% -25.02%
EBIT Margin
-193.41% -320.43% -534.32% -699.89% -25.02%
Profit (Net Income) Margin
-244.85% -108.06% -523.36% -593.12% -39.96%
Tax Burden Percent
58.28% 68.03% 93.10% 84.74% 106.57%
Interest Burden Percent
217.22% 49.57% 105.21% 100.00% 149.82%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% -140.65% -94.52% -162.99% -25.60%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -90.97% -114.67% -172.84% -37.78%
Return on Net Nonoperating Assets (RNNOA)
0.00% 290.34% 241.25% 236.70% 60.07%
Return on Equity (ROE)
0.00% 149.70% 146.73% 73.72% 34.47%
Cash Return on Invested Capital (CROIC)
0.00% -340.65% -140.69% -19.05% -186.55%
Operating Return on Assets (OROA)
0.00% -50.33% -73.52% -73.21% -13.37%
Return on Assets (ROA)
0.00% -16.97% -72.01% -62.04% -21.36%
Return on Common Equity (ROCE)
0.00% 1,253.70% 578.22% 186.40% 117.41%
Return on Equity Simple (ROE_SIMPLE)
0.00% 74.85% 90.99% 59.17% 56.17%
Net Operating Profit after Tax (NOPAT)
-96 -209 -365 -451 -102
NOPAT Margin
-138.63% -222.50% -372.17% -484.54% -17.52%
Net Nonoperating Expense Percent (NNEP)
0.00% -49.67% 20.15% 9.85% 12.17%
Return On Investment Capital (ROIC_SIMPLE)
- - -59.31% -338.14% -13.24%
Cost of Revenue to Revenue
0.00% 124.94% 257.32% 460.12% 84.18%
SG&A Expenses to Revenue
84.83% 89.57% 190.30% 82.30% 11.32%
R&D to Revenue
213.21% 203.34% 184.06% 226.64% 29.52%
Operating Expenses to Revenue
298.04% 292.91% 374.36% 332.08% 40.85%
Earnings before Interest and Taxes (EBIT)
-134 -301 -524 -651 -145
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-118 -283 -504 -627 -114
Valuation Ratios
- - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.00 0.00 0.00 30.69 6.08
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 65.72 9.30
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 54.76 11.49
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - -
Debt to Equity
0.00 -3.80 -2.09 -1.14 -2.86
Long-Term Debt to Equity
0.00 -3.78 -2.06 -1.10 -2.78
Financial Leverage
0.00 -3.19 -2.10 -1.37 -1.59
Leverage Ratio
0.00 -4.41 -2.04 -1.19 -1.61
Compound Leverage Factor
0.00 -2.19 -2.14 -1.19 -2.42
Debt to Total Capital
0.00% 135.67% 191.66% 799.56% 153.75%
Short-Term Debt to Total Capital
0.00% 0.73% 3.23% 28.53% 4.26%
Long-Term Debt to Total Capital
0.00% 134.94% 188.43% 771.03% 149.49%
Preferred Equity to Total Capital
0.00% 263.09% 171.89% 922.51% 261.35%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% -298.76% -263.55% -1,622.07% -315.10%
Debt to EBITDA
0.00 -1.82 -2.34 -1.70 -10.37
Net Debt to EBITDA
0.00 -1.53 -2.06 -1.61 -9.91
Long-Term Debt to EBITDA
0.00 -1.81 -2.30 -1.64 -10.08
Debt to NOPAT
0.00 -2.47 -3.23 -2.36 -11.62
Net Debt to NOPAT
0.00 -2.07 -2.85 -2.24 -11.11
Long-Term Debt to NOPAT
0.00 -2.45 -3.18 -2.28 -11.29
Altman Z-Score
0.00 0.00 0.00 -4.59 -1.16
Noncontrolling Interest Sharing Ratio
0.00% -737.48% -294.07% -152.86% -240.60%
Liquidity Ratios
- - - - -
Current Ratio
0.00 1.07 1.38 0.75 2.35
Quick Ratio
0.00 0.43 0.60 0.20 1.10
Cash Flow Metrics
- - - - -
Free Cash Flow to Firm (FCFF)
0.00 -506 -544 -53 -741
Operating Cash Flow to CapEx
-823.02% -561.54% -1,380.36% -673.68% -867.63%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 -19.90 0.00 -10.68
Operating Cash Flow to Interest Expense
-0.38 0.00 -19.15 0.00 -6.71
Operating Cash Flow Less CapEx to Interest Expense
-0.42 0.00 -20.53 0.00 -7.48
Efficiency Ratios
- - - - -
Asset Turnover
0.00 0.16 0.14 0.10 0.53
Accounts Receivable Turnover
0.00 3.08 3.02 2.43 5.73
Inventory Turnover
0.00 3.00 4.57 5.87 4.83
Fixed Asset Turnover
0.00 1.20 0.66 0.41 2.23
Accounts Payable Turnover
0.00 4.02 6.35 6.54 6.61
Days Sales Outstanding (DSO)
0.00 118.54 120.93 150.49 63.69
Days Inventory Outstanding (DIO)
0.00 121.47 79.88 62.21 75.59
Days Payable Outstanding (DPO)
0.00 90.89 57.49 55.81 55.18
Cash Conversion Cycle (CCC)
0.00 149.12 143.33 156.90 84.11
Capital & Investment Metrics
- - - - -
Invested Capital
0.00 297 476 78 717
Invested Capital Turnover
0.00 0.63 0.25 0.34 1.46
Increase / (Decrease) in Invested Capital
0.00 297 178 -398 639
Enterprise Value (EV)
0.00 0.00 0.00 5,094 6,666
Market Capitalization
0.00 0.00 0.00 2,854 3,530
Book Value per Share
$0.00 $0.00 ($6.53) ($8.70) ($9.07)
Tangible Book Value per Share
$0.00 $0.00 ($6.68) ($8.82) ($9.19)
Total Capital
0.00 380 616 133 768
Total Debt
0.00 516 1,180 1,066 1,181
Total Long-Term Debt
0.00 513 1,160 1,028 1,148
Net Debt
0.00 433 1,040 1,010 1,129
Capital Expenditures (CapEx)
7.41 41 38 46 54
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -17 -8.26 -65 243
Debt-free Net Working Capital (DFNWC)
0.00 11 83 -28 294
Net Working Capital (NWC)
0.00 7.98 63 -66 262
Net Nonoperating Expense (NNE)
74 -107 148 101 130
Net Nonoperating Obligations (NNO)
0.00 433 1,040 1,010 1,129
Total Depreciation and Amortization (D&A)
16 18 20 24 31
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -17.98% -8.41% -70.28% 41.86%
Debt-free Net Working Capital to Revenue
0.00% 11.45% 84.94% -30.19% 50.72%
Net Working Capital to Revenue
0.00% 8.50% 64.65% -71.07% 45.09%
Earnings Adjustments
- - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($2.60) ($2.43) ($0.87)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 248.65M 266.82M 301.81M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($2.60) ($2.43) ($0.87)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 248.65M 266.82M 301.81M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 248.65M 266.82M 301.81M
Normalized Net Operating Profit after Tax (NOPAT)
-96 -209 -365 -436 -102
Normalized NOPAT Margin
-138.63% -222.50% -372.17% -468.35% -17.52%
Pre Tax Income Margin
-420.12% -158.83% -562.15% -699.89% -37.49%
Debt Service Ratios
- - - - -
EBIT to Interest Expense
-0.83 0.00 -19.20 0.00 -2.09
NOPAT to Interest Expense
-0.60 0.00 -13.37 0.00 -1.47
EBIT Less CapEx to Interest Expense
-0.88 0.00 -20.59 0.00 -2.87
NOPAT Less CapEx to Interest Expense
-0.64 0.00 -14.76 0.00 -2.24
Payout Ratios
- - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% -0.75% 0.00%

Quarterly Metrics and Ratios for Alvotech

No quarterly metrics and ratios for Alvotech are available.


Frequently Asked Questions About Alvotech's Financials

When does Alvotech's financial year end?

According to the most recent income statement we have on file, Alvotech's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Alvotech's net income changed over the last 4 years?

Alvotech's net income appears to be on an upward trend, with a most recent value of -$231.86 million in 2024, rising from -$170.04 million in 2020. The previous period was -$551.73 million in 2023.

What is Alvotech's operating income?
Alvotech's total operating income in 2024 was -$145.22 million, based on the following breakdown:
  • Total Gross Profit: $91.81 million
  • Total Operating Expenses: $237.03 million
How has Alvotech revenue changed over the last 4 years?

Over the last 4 years, Alvotech's total revenue changed from $69.45 million in 2020 to $580.28 million in 2024, a change of 735.6%.

How much debt does Alvotech have?

Alvotech's total liabilities were at $1.63 billion at the end of 2024, a 13.2% decrease from 2023, and a 122.8% increase since 2021.

How much cash does Alvotech have?

In the past 3 years, Alvotech's cash and equivalents has ranged from $11.16 million in 2023 to $66.43 million in 2022, and is currently $51.43 million as of their latest financial filing in 2024.

How has Alvotech's book value per share changed over the last 4 years?

Over the last 4 years, Alvotech's book value per share changed from 0.00 in 2020 to -9.07 in 2024, a change of -906.9%.

Remove Ads


This page (NASDAQ:ALVO) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners